The Stimulating Effect of Rosmarinic Acid and Extracts from Rosemary and Lemon Balm on Collagen Type I Biosynthesis in Osteogenesis Imperfecta Type I Skin Fibroblasts
Overview
Authors
Affiliations
Rosemary extract (RE) and lemon balm extract (LBE) attract particular attention of pharmacists due to their high therapeutic potential. Osteogenesis imperfecta (OI) type I is a heritable disease caused by mutations in type I collagen and characterized by its reduced amount. The aim of the study was to evaluate the effect of the extracts and rosmarinic acid (RA) on collagen type I level in OI skin fibroblasts. Phytochemical analysis of RE and LBE was carried out by liquid chromatography-photodiode array detection-mass spectrometry. The expression of collagen type I at transcript and protein levels was analyzed by qPCR, ELISA, SDS-urea PAGE, and Western blot. In OI patient's fibroblasts the exposure to the extracts (0.1-100 µg/mL) and RA (0.1-100 µM) significantly increased collagen type I and the best results were obtained with 0.1-10 µM RA and 0.1-10 µg/mL of the extracts. LBE showed a greater stimulating effect than RE, likely due to a higher RA content. Moreover, collagen type III expression and matrix metalloproteinase (MMP-1, -2, -9) activity remained unchanged or decreased. The obtained data support the clinical potential of RA-rich extracts and RA itself in modulating the quantitative defect of type I collagen in type I OI.
Reversing Glycation with a Dietary Supplement Containing Rosemary Extract.
Draelos Z, Bucay V, Watchmaker J, Valacchi G J Clin Aesthet Dermatol. 2025; 18(2):44-49.
PMID: 40078862 PMC: 11896625.
Jiang M, Qiu Z, Diao Y, Shi Y, Liu W, Li N BMC Complement Med Ther. 2024; 24(1):251.
PMID: 38956573 PMC: 11221082. DOI: 10.1186/s12906-024-04554-7.
Charoensin S, Dansakda S Molecules. 2023; 28(14).
PMID: 37513476 PMC: 10384106. DOI: 10.3390/molecules28145599.
Sutkowska-Skolimowska J, Branska-Januszewska J, Strawa J, Ostrowska H, Botor M, Gawron K Int J Mol Sci. 2022; 23(18).
PMID: 36142253 PMC: 9499644. DOI: 10.3390/ijms231810341.
Biomedical features and therapeutic potential of rosmarinic acid.
Noor S, Mohammad T, Rub M, Raza A, Azum N, Yadav D Arch Pharm Res. 2022; 45(4):205-228.
PMID: 35391712 PMC: 8989115. DOI: 10.1007/s12272-022-01378-2.